These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 15476157)

  • 81. Impact of body mass index in liver transplantation for nonalcoholic fatty liver disease and alcoholic liver disease.
    O'Neill S; Napetti S; Cornateanu S; Sutherland AI; Wigmore S; Oniscu GC; Adair A
    HPB (Oxford); 2017 Dec; 19(12):1074-1081. PubMed ID: 28888774
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Clinical characteristics of non-B non-C hepatocellular carcinoma: a single-center retrospective study.
    Kim SK; Marusawa H; Eso Y; Nishikawa H; Ueda Y; Kita R; Kimura T; Chiba T; Osaki Y; Kudo M
    Digestion; 2011; 84 Suppl 1():43-9. PubMed ID: 22156485
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma.
    Rabe C; Pilz T; Klostermann C; Berna M; Schild HH; Sauerbruch T; Caselmann WH
    World J Gastroenterol; 2001 Apr; 7(2):208-15. PubMed ID: 11819762
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Clinical outcomes of lamivudine-adefovir therapy in chronic hepatitis B cirrhosis.
    Lim SG; Aung MO; Mak B; Sutedja D; Lee YM; Lee GH; Fernandes M; Low HC; Lai V; Dan YY
    J Clin Gastroenterol; 2011 Oct; 45(9):818-23. PubMed ID: 21921845
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Impact of obesity and diabetes on waitlist survival, probability of liver transplantation and post-transplant survival among chronic hepatitis C virus patients.
    Aguilar M; Liu B; Holt EW; Bhuket T; Wong RJ
    Liver Int; 2016 Aug; 36(8):1167-75. PubMed ID: 26858016
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
    Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
    Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Systematic review with meta-analysis on transplantation for alcohol-related liver disease: Very low evidence of improved outcomes.
    Shen NT; Londono C; Gold S; Wu A; Mages KC; Brown RSJ
    World J Gastroenterol; 2019 Apr; 25(13):1628-1639. PubMed ID: 30983822
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism.
    Björnsson E; Olsson J; Rydell A; Fredriksson K; Eriksson C; Sjöberg C; Olausson M; Bäckman L; Castedal M; Friman S
    Scand J Gastroenterol; 2005 Feb; 40(2):206-16. PubMed ID: 15764153
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response.
    Casado JL; Esteban MA; Bañón S; Moreno A; Perez-Elías MJ; Mateos ML; Moreno S; Quereda C
    Dig Dis Sci; 2015 Nov; 60(11):3473-81. PubMed ID: 26112991
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis.
    Mettke F; Schlevogt B; Deterding K; Wranke A; Smith A; Port K; Manns MP; Vogel A; Cornberg M; Wedemeyer H
    Aliment Pharmacol Ther; 2018 Feb; 47(4):516-525. PubMed ID: 29205405
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The interaction of alcoholic liver disease and hepatitis C.
    Marsano LS; Peña LR
    Hepatogastroenterology; 1998; 45(20):331-9. PubMed ID: 9638402
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Development of colorectal cancer predicts increased risk of subsequent hepatocellular carcinoma in patients with alcoholic liver disease: case-control and cohort study.
    Kim W; Jeong D; Chung J; Lee D; Joo S; Jang ES; Choi YJ; Yoon H; Shin CM; Park YS; Jeong SH; Kim N; Lee DH; Kim JW
    Sci Rep; 2019 Mar; 9(1):3236. PubMed ID: 30824851
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Excess Mortality After Liver Transplantation in Young Women With Alcohol-Associated Liver Disease.
    Lee BP; Dodge JL; Terrault NA
    Am J Gastroenterol; 2021 Mar; 116(3):551-559. PubMed ID: 33136566
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019.
    Wang S; Toy M; Hang Pham TT; So S
    PLoS One; 2020; 15(9):e0239393. PubMed ID: 32946502
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Liver transplantation for hepatitis C and alcoholic liver disease.
    Carbone M; Neuberger J
    J Transplant; 2010; 2010():893893. PubMed ID: 21209701
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Incidence of cirrhosis in Iceland-impact of the TraP HepC nationwide HCV elimination program.
    Haraldsson HA; Olafsson S; Gottfredsson M; Benitez Hernandez U; Bjornsson ES
    Scand J Gastroenterol; 2024 Jul; 59(7):835-842. PubMed ID: 38676467
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder.
    Chiu WC; Shan JC; Yang YH; Chen VC; Chen PC
    Drug Alcohol Depend; 2021 Nov; 228():109096. PubMed ID: 34600254
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Long-term Liver-related Outcomes of Patients With Chronic Liver Diseases in Australia.
    Huang Y; Joseph J; de Boer WB; Cheng W; Adams LA; MacQuillan G; Garas G; Raftopoulos S; Jeffrey GP
    Clin Gastroenterol Hepatol; 2020 Feb; 18(2):496-504.e3. PubMed ID: 31319186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.